Suppr超能文献

[去乙酰化酶(SIRT1)的研究进展]

[Research progression of deacetylase (SIRT1)].

作者信息

Chen Hou-zao, Zhang Zhu-qin, Wei Yu-sheng, Liu De-pei

机构信息

National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, CAMS and PUMC, Beijing 100005, China.

出版信息

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Jun;29(3):441-7.

Abstract

The silent information regulator protein 2 (Sir2) and its homologues play an important role in the regulation of cellular physiological processes such as survival, apoptosis, and aging. SIRT1, the mammalian Sir 2 homologue, has been shown to deacetylate a wide range of non-histone substrates and histone substrates. It has been constantly reported that SIRT1 may be associated with the occurrence of metabolic syndrome, genomic homeostasis, tumors, and neurodegenerative diseases. Calorie restriction may mitigate many major diseases in rodent models by SIRT1-mediated deacetylase activity and prolong the life expectancies in these animals. Therefore, SIRT1 may be emphasized as a new therapy target for many different diseases.

摘要

沉默信息调节蛋白2(Sir2)及其同源物在调节细胞生理过程(如存活、凋亡和衰老)中发挥重要作用。哺乳动物Sir2同源物SIRT1已被证明可使多种非组蛋白底物和组蛋白底物去乙酰化。不断有报道称,SIRT1可能与代谢综合征、基因组稳态、肿瘤和神经退行性疾病的发生有关。在啮齿动物模型中,热量限制可能通过SIRT1介导的脱乙酰酶活性减轻许多重大疾病,并延长这些动物的预期寿命。因此,SIRT1可能被视为针对多种不同疾病的新治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验